Biotech SF: Abaxis

Showing posts with label Abaxis. Show all posts

Thursday, September 27, 2012

Abaxis to get $17M in settlement with Cepheid

Medical products maker Abaxis Inc. will get $17.25 million in a settlement with Cepheid Inc. Sunnyvale-based Cepheid (NASDAQ: CPHD) will pay the money to Union City-based Abaxis (NASDAQ: ABAX) without admitting wrongdoing, but to "terminate all pending and future claims connected with the litigation." The dispute, in which both companies made claims and counterclaims, concerned several patents held by Abaxis over reagent and chemical compositions and processes.

Friday, February 11, 2011

Abaxis invests $2.8M into veterinary company

Tuesday, January 25, 2011

Abaxis inks $30 million supply deal with Becton Dickinson

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.